Eye health

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

What kind of health claims will be made on the Vitafoods show floor this year?

Vitafoods: EU nutra space wriggles into new health claims clothes

By Shane Starling

Vitafoods celebrates its 15th birthday next week. It’ll be my 11th consecutive May visit to Geneva for the jamboree and promises to be one of the most intriguing chapters with the (partial and belated) resolution of years of ambiguity regarding health...

DSM readies €2bn+ acquisitions war chest as 2011 profit jumps 15%

DSM readies €2bn+ acquisitions war chest as 2011 profit jumps 15%

By Shane Starling

Nutrition and polymers were the stand-out divisions for Royal DSM in 2011, a year that saw operating profits rise 15% from €752m to €866m, as the newly life science-oriented ingredients giant singled out Martek buy-out success and committed to ongoing...

Icelandic omega-3 firm doubles capacity

Icelandic omega-3 firm doubles capacity

By Shane Starling

Iceland-based omega-3 and fish oil specialist Lysi is doubling input and output capacity at its central production facility in the island’s capital, Reykjavik.

Health claims register enters European Parliament as veto calls rise

Health claims register enters European Parliament as veto calls rise

By Shane Starling

Paola Testori Coggi, the director general of the EC’s Health and Consumer Health Directorate (DG Sanco), yesterday presented a health claims register containing 222 approvals and about 2000 rejections to a European Parliament (EP) committee, as lobbying...

Zeaxanthin may match lutein for MPOD boost: RCT

Zeaxanthin may match lutein for MPOD boost: RCT

By Stephen Daniells

Supplements of zeaxanthin may increase the macula pigment optical density (MPOD) as much as lutein, and boost the functioning of cones in retina, says a new study.

Zeaxanthin improves elderly vision

Zeaxanthin improves elderly vision

Elderly people have better night vision and are better able to discern fine details, when taking zeaxanthin, a military study has found.

Squid: High in DHA, the omega-3 fatty acid associated with brain development and eye health

Squid gains traction in omega-3 market

By Elaine Watson

The Norwegian entrepreneurs behind Pharma Marine - a new business set up to commercialize long chain omega-3s from the trimmings of food-grade calamari - have struck deals with a clutch of leading players in the US supplements industry just two years...

Meta-analysis supports lutein’s eye health benefits

Meta-analysis supports lutein’s eye health benefits

By Stephen Daniells

High dietary intake of lutein and zeaxanthin, compounds with a long history of eye health benefits, may reduce the risk of late-stage age-related macular degeneration (AMD), but they show little effect in the early stages of the disease, claims a new...

After a conference last year, academics have increased pressure to reform the NHCR by publishing a long paper in 'Nutrition'

Academics slam 'medicine-based' EU health claims system

By Shane Starling

A group of 13 academics has slammed the EU nutrition and health claims regulation (NHCR) for its ‘evidence based medicinal’ approach that rules out what they view as perfectly valid nutrition science.

Beyond the heart and brain: Emerging benefits of omega-3

Special edition: Omega-3

Beyond the heart and brain: Emerging benefits of omega-3

By Nathan Gray

Omega-3 fatty acids have a wide range of reported benefits, some of which have more scientific support than others. As part of our special focus on omega-3’s, NutraIngredients takes a look at some of the emerging benefits that are currently less well...

Van Der Meulen: Scale, efficiency, sustainability

Special edition: Omega-3

Aurora Algae ups ante in omega-3 market with plans for Q4, 2012 launch

By Elaine Watson

Aurora Algae – the firm promising to turn up the heat in the algal omega-3 market by producing a concentrated 65% EPA-rich oil on a completely new scale – aims to ship out its first commercial products in the fourth quarter of 2012.

The first phase of an expansion at Neptune’s facility in Sherbrooke, Quebec, should be completed by March 2012

Neptune promises productivity boost as sales rise but profits slide

By Elaine Watson

Canadian krill oil firm Neptune Technologies & Bioressources posted a modest rise in revenues in the first quarter of 2012 but said its bottom line had suffered owing to changes in exchange rates, a switch to International Financial Reporting Standards...

AlgaeBio unveils production stats as algal omega-3 market heats up

AlgaeBio unveils production stats as algal omega-3 market heats up

By Elaine Watson

Algae Biosciences Corporation – a high-profile new entrant to the omega-3 fatty acid market – has unveiled detailed figures on anticipated production volumes after finalizing a deal to build the first phase of its new production facility near Holbrook...

Cyanotech is based in Kona, Hawaii

Astaxanthin sales surge 97 percent at Cyanotech in Q1

By Elaine Watson

Hawaii-based Cyanotech has posted a dramatic rise in sales in the first quarter of 2012 driven by growing demand for natural astaxanthin: a potent red antioxidant that hit the headlines earlier this year following favorable coverage on Dr Oz and Oprah.

“Perhaps the brain is the last place you want to lose vitamin C

Vitamin C shows eyes & brain health potential: Study

By Stephen Daniells

One of the nutrition industry’s biggest sellers – vitamin C – may help nerve cells in the eye to function properly, says a new study that suggests the vitamin may also be important for brain function, too.

Astaxanthin won't help protect the skin from UV damage, says EFSA

EFSA health claim opinion

Astaxanthin health claim rejection “not a big surprise”

By Shane Starling

Astaxanthin suppliers have expressed disappointment at last week’s rejection of the carotenoid by the European Food Safety Authority (EFSA) health claims panel, but said the rejection was not unexpected given the agency’s treatment of other carotenoids...

British MEP Glenis Willmott has not given up on blocking claims such as this one on infant foods despite EFSA, the EC and the EP approving them

MEP takes DHA omega-3 claim complaint back to the Commission

By Shane Starling

British Labour Member of the European Parliament (MEP), Glenis Willmott, is writing to the European Commission to block a DHA eye development claim being used on infant follow-on formula products, after the EP last week failed to veto the claim.

MEPs have authorised a DHA-eye health claim for infants

MEPs authorise omega-3 infant eye health claim

By Shane Starling

Members of the European Parliament (MEPs) have today narrowly rejected a motion to prohibit a European Food Safety Authority (EFSA) and European Commission (EC)-approved DHA omega-3 eye health claim on breast milk substitute products.

From blood to eye lutein bioavailibility differs due to its form and in transit, says professor Norkus

Lutein: The eyes have it - or do they?

By Shane Starling

It is well known that free lutein has greater bioavailability than its esterified cousins. Here professor Edward Norkus, PhD, from the Montefiore Medical Center, New York City explains just why that is the case for the eye health nutrient.